JP Morgan Chase
AVNS

JP Morgan Chase’s Avanos Medical AVNS Stock Holding History

JP Morgan Chase’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,400
Closed -$52K – 5036
2016
Q4 		$52K Buy
+1,400
New +$50K ﹤0.01% 4538
2016
Q3 		– Sell
-40,000
Closed -$1.3M – 4534
2016
Q2 		$1.3M Buy
+40,000
New +$1.23M ﹤0.01% 3041
2016
Q1 		– Sell
-1,800
Closed -$60K – 4650
2015
Q4 		$60K Buy
+1,800
New +$56K ﹤0.01% 3883

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

JP Morgan Chase's AVNS Position: Q1 2026 in Review

JP Morgan Chase reduced its Avanos Medical (AVNS) stake by 8.2% in Q1 2026, selling an estimated $304K and leaving 251,162 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3666.

JP Morgan Chase first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $39M in Q4 2017. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • JP Morgan Chase held 251,162 shares of Avanos Medical worth $3.45M as of Q1 2026.
  • JP Morgan Chase sold 22,556 Avanos Medical shares in Q1 2026, an estimated $304K.
  • Avanos Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3666 holding.
  • JP Morgan Chase first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
  • JP Morgan Chase's Avanos Medical position peaked at $39M in Q4 2017.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.